RT Journal Article
SR Electronic
T1 Update on contraception: Benefits and risks of the new formulations
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP 681
OP 695
VO 70
IS 8
A1 Batur, Pelin
A1 Elder, Julie
A1 Mayer, Mark
YR 2003
UL http://www.ccjm.org/content/70/8/681.abstract
AB Several new contraceptives have become available to women in recent years. These new agents include ultra-low-dose oral contraceptives as well as injectable, vaginal, and patch formulations. We review these, with emphasis on the Yasmin pill (which contains a new progestin), the Lunelle once-a-month injection, the Ortho Evra patch, the NuvaRing vaginal ring, the Mirena intrauterine device, and emergency contraceptive kits. Patient education regarding these options is essential for patient compliance and satisfaction.